Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CETP | P11597 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3897583 | 0.75 | ALDH1A1 (0.41) | L3MBTL1LMNAMEN1KMT2ATSHR | |
| SCHEMBL8779724 | 0.74 | ALDH1A1 (0.46) | EPHX2L3MBTL1LMNAKMT2ATSHR | |
| SCHEMBL20710698 | 0.72 | LTA4H (0.52) | LTA4HEPHX2L3MBTL1LMNACETP | |
| SCHEMBL12229745 | 0.72 | MEN1 (0.48) | LTA4HEPHX2LMNACETPMEN1 | |
| SCHEMBL8922170 | 0.70 | CYP2C19 (0.53) | LTA4HEPHX2LMNAMEN1KMT2A | |
| SCHEMBL13479771 | 0.68 | TP53 (0.54) | L3MBTL1CETPTSHRALDH1A1NPC1 | |
| SCHEMBL13535130 | 0.68 | LTA4H (0.40) | LTA4HEPHX2L3MBTL1LMNACETP | |
| SCHEMBL358474 | 0.67 | MEN1 (0.59) | L3MBTL1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL6794322 | 0.67 | LTA4H (0.67) | LTA4HEPHX2L3MBTL1LMNAMEN1 | |
| SCHEMBL27678665 | 0.67 | ALDH1A1 (0.49) | L3MBTL1LMNAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572459-B2 | Prevention infections in humans, animals | STARPHARMA PTY LTD. (AU) | 2009-08-11 | — | — | US | disclosed |
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | STARPHARMA LIMITED | 2003-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030129158-A1 | Anionic or cationic dendrimer antimicrobial or antiparasitic compositions | FUT6, B3GNT2, SIGLEC7 | LTA4H 1186/4885EPHX2 3429/4885L3MBTL1 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.